Evolve Mind Wellness has a long-term vision of providing future psychedelic-assisted treatments and therapies as they become FDA-approved and legal for clinical office use. We are actively participating in psychedelic medicine training and research programs such as MDMA for PTSD through MAPS. The FDA has provided ‘break through status’ for both MDMA and Psilocybin-assisted psychotherapy. Results of Phase 2 studies demonstrate that they are more effective than currently available treatments, and the FDA has expedited them through the approval process. It is our goal to offer these psychedelic medicines in the future as they become legally available for clinical practice. For more information click here.